These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 17182155)
1. Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909. Wahid R; Salerno-Gonçalves R; Tacket CO; Levine MM; Sztein MB Vaccine; 2007 Feb; 25(8):1416-25. PubMed ID: 17182155 [TBL] [Abstract][Full Text] [Related]
2. Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA. Salerno-Gonçalves R; Wyant TL; Pasetti MF; Fernandez-Viña M; Tacket CO; Levine MM; Sztein MB J Immunol; 2003 Mar; 170(5):2734-41. PubMed ID: 12594304 [TBL] [Abstract][Full Text] [Related]
3. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide. Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933 [TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909. Wang JY; Noriega FR; Galen JE; Barry E; Levine MM Infect Immun; 2000 Aug; 68(8):4647-52. PubMed ID: 10899868 [TBL] [Abstract][Full Text] [Related]
5. Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans. Wahid R; Pasetti MF; Maciel M; Simon JK; Tacket CO; Levine MM; Sztein MB Clin Immunol; 2011 Feb; 138(2):187-200. PubMed ID: 21146460 [TBL] [Abstract][Full Text] [Related]
6. Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes. Pasetti MF; Salerno-Gonçalves R; Sztein MB Infect Immun; 2002 Aug; 70(8):4009-18. PubMed ID: 12117906 [TBL] [Abstract][Full Text] [Related]
7. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors. Levine MM; Galen J; Barry E; Noriega F; Chatfield S; Sztein M; Dougan G; Tacket C J Biotechnol; 1996 Jan; 44(1-3):193-6. PubMed ID: 8717403 [TBL] [Abstract][Full Text] [Related]
8. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. Salerno-Goncalves R; Pasetti MF; Sztein MB J Immunol; 2002 Aug; 169(4):2196-203. PubMed ID: 12165550 [TBL] [Abstract][Full Text] [Related]
10. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110 [TBL] [Abstract][Full Text] [Related]
11. Experience with registered mucosal vaccines. Dietrich G; Griot-Wenk M; Metcalfe IC; Lang AB; Viret JF Vaccine; 2003 Jan; 21(7-8):678-83. PubMed ID: 12531339 [TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans. Sztein MB Clin Infect Dis; 2007 Jul; 45 Suppl 1():S15-9. PubMed ID: 17582562 [TBL] [Abstract][Full Text] [Related]
13. Vi Capsular Polysaccharide Produced by Recombinant Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685 [TBL] [Abstract][Full Text] [Related]
14. Immune response of infants and preschool children to typhoid vaccine given intradermally or subcutaneously. Mohandas V; Cherian T; Sridharan G; Simoes EA; Pereira SM; John TJ BMJ; 1989 Jan; 298(6667):162-3. PubMed ID: 2493838 [No Abstract] [Full Text] [Related]
15. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations. Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948 [TBL] [Abstract][Full Text] [Related]
16. Age-Associated Heterogeneity of Ty21a-Induced T Cell Responses to HLA-E Restricted Rudolph ME; McArthur MA; Magder LS; Barnes RS; Chen WH; Sztein MB Front Immunol; 2019; 10():257. PubMed ID: 30886613 [TBL] [Abstract][Full Text] [Related]